All sources from FreeEdgar.  Their phone number from the 10KSB filed 7/29/98 is: 	  BUSINESS ADDRESS:         STREET1:  191 UNIVERSITY BLVD #302       STREET2:  STE 3290       CITY:  DENVER       STATE:  CO       ZIP:  80206       PHONE:  3033293033
 
  Note that this is different than the phone number in the header of the filing, but that seems to be for someone else:
 
   TYPE:  10KSB  SEQUENCE:  1  DESCRIPTION:  FORM 10-KSB
                      U. S. SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C. 20549
                                     FORM 10-KSB
  (Mark One)
    X -----     Annual  Report  Pursuant  to  Section  13 or 15(d)  of the  Securities           Exchange Act of 1934 (Fee Required)
  -----     Transition  Report  Pursuant to Section 13 or 15(d) of the  Securities           Exchange Act of 1934 (No Fee Required)
  For the fiscal year ended April 30, 1998
  Commission file number 0-9064
                            APPLIED MEDICAL DEVICES, INC.                   --------------------------------------------                  (Name of small business issuer in its charter)
              Colorado                                            84-0789885             --------                                            ---------- (State or other jurisdiction of                              (I.R.S. Employer incorporation or organization)                            Identification Number)
  1722 Buffehr Creek Road, Vail, CO                                  81657 ---------------------------------                                  ----- (Address of principal executive offices)                         (Zip Code)
                                  (former address)           8100 W. Crestline Avenue, Suite A-15, #330, Denver, CO 80123
  Issuer's telephone number  (970) 479-2800
  Securities  registered  pursuant  to Section  12(b) of the  Exchange  Act : None Securities registered pursuant to Section 12(g) of the Exchange Act:
       Common Stock, $.01 Par Value
  Check  whether the issuer (1) filed all reports  required to be filed by Section 13 or 15(d) of the Securities Exchange Act during the past 12 months and (2) has been subject to such filing requirements for the past 90 days.
                                  Yes  X   No                                    -----   -----
  Check if there is no  disclosure of  delinquent  filers  pursuant to Item 405 of Regulation S-B is not contained herein,  and will not be contained,  to the best of  Registrant's  knowledge,  in  definitive  proxy  or  information  statements incorporated  by reference  in Part III of this Form 10-KSB or any  amendment to this Form 10-KSB. [ X ]
  The issuer  had  approximately  $87,00 in  interest  revenue in its most  recent fiscal year.
  The  aggregate  market  value of the  voting  stock held by  non-affiliates  was approximately  $51,720 based upon the bid price of the stock on June 29, 1998 of $.001. However, trading in the stock is limited and sporadic. See Item 5.
  The number of shares of the Registrant's $.01 par value common stock outstanding as of June 29, 1998 was 65,977,800.
  |